CKD increase mortality rate in patients with sickle cell disease: Study Jacinthlyn Sylvia16 May 2024 5:45 AM ISTSickle cell disease (SCD) and sickle cell trait have long been associated with a wide extent of renal complications with implications that range from...
Tricuspid regurgitation velocity tied to kidney, cerebrovascular disease in children with sickle cell disease: Study Medha Baranwal9 May 2024 9:15 PM ISTUSA: A cross-sectional, multicenter study has shed light on a concerning association between elevated tricuspid regurgitation velocity (TRV) and the...
Submit Interim Safety, Efficacy Data: CDSCO Panel Tells Novartis on Crizanlizumab Dr. Divya Colin20 March 2024 6:00 PM ISTNew Delhi: Reviewing the status of the ongoing studies of Crizanlizumab concentrate for solution for infusion 10mg/mL (100mg/10mL), the Subject Expert...
Pfizer Gets CDSCO Panel Nod To study Osivelotor in sickle cell disease Dr. Divya Colin19 March 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to drug...
Medical Bulletin 8/January/2024 Anshika Mishra8 Jan 2024 3:00 PM ISTHere are the top medical news of the day:Most babies with sickle cell disease face double disadvantageAs if starting life with a potentially disabling...
Most babies with sickle cell disease face double disadvantage Anshika Mishra8 Jan 2024 9:00 AM ISTAs if starting life with a potentially disabling genetic blood disease wasn't enough, a study shows that almost two-thirds of babies born with sickle...
Propranolol could be new treatment for sickle cell cardiomyopathy Dr. Kamal Kant Kohli5 Jan 2024 4:15 AM ISTA beta blocker typically used to treat heart problems, hemangioma, migraines and anxiety could be a new therapeutic for patients with sickle cell...
FDA Approves First Gene based Therapies for treatment of patients with Sickle Cell Disease Dr. Kamal Kant Kohli9 Dec 2023 10:30 AM ISTThe U.S. Food and Drug Administration has approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies...
From Rs 2.5 Crore pa to Rs 2.5 lakh per annum: Soon, make in India drugs for rare diseases Roshni Dhar29 Nov 2023 11:00 AM ISTThe Centre has come up with a game-changer special initiative by manufacturing four types of homegrown 'Made in India' drugs for rare diseases for the...
Health Bulletin 28/November/2023 Roshni Dhar28 Nov 2023 5:02 PM ISTHere are the top health stories for the day:MCC releases revised schedule for NEET SS Counselling 2023, Round 1 reporting deadline extended, know...
From Rs 2.5 crore pa to Rs 2.5 Lakh per annum: Soon, Make in India drugs for rare diseases to change medicine spectrum Ruchika Sharma27 Nov 2023 3:27 PM IST4 Make in India drugs for Tyrosinemia Type, Gaucher's Disease, Wilson's Disease and Dravet or Lennox Gastaut Syndrome- seizures have been announced,...
Medical Bulletin 01/September/2023 Isra Zaman1 Sept 2023 3:30 PM ISTHere are the top medical news of the day:Promising evidence for sickle cell gene therapy found in new studyNew research published in the New England...
